• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ares Capital Corporation - Closed End Fund (NQ:ARCC)

    20.38 -0.21 (-1.04%)
    Streaming Delayed Price Updated: 11:58 AM EST, Jan 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,706,837
    Open 20.61
    Bid (Size) 20.37 (3,000)
    Ask (Size) 20.38 (1,900)
    Prev. Close 20.59
    Today's Range 20.25 - 20.66
    52wk Range 18.26 - 23.84
    Shares Outstanding 716,000,000
    Dividend Yield 9.42%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Top Dividend Stocks to Buy in January ↗
    These dividend stocks are in a league of their own. 
    Via The Motley Fool
    Topics Energy Initial Public Offering
    News headline image
    Ares Capital Corporation Schedules Earnings Release for the Fourth Quarter and Fiscal Year Ended December 31, 2025
    Via ACCESS Newswire

    Performance

    YTD
    -0.3%
    -0.3%
    1 Month
    -3.1%
    -3.1%
    3 Month
    +2.6%
    +2.6%
    6 Month
    -9.1%
    -9.1%
    1 Year
    -7.9%
    -7.9%

    More News

    Read More
    News headline image
    Investing $50,000 in Each of These 5 Stocks Could Make You Over $20,600 in Passive Income in 2026 ↗
    Via The Motley Fool
    Topics Energy
    News headline image
    The Best Dividend Stocks to Buy With $2,000 Right Now ↗
    Via The Motley Fool
    News headline image
    Ares Capital Corporation Prices Public Offering of $750 Million 5.250% Unsecured Notes Due 2031
    From Ares Capital Corporation
    Via Business Wire
    News headline image
    26 Top Dividend Stocks to Buy and Hold in 2026 ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Better Dividend Stock: Ares Capital vs. Main Street Capital ↗
    Via The Motley Fool
    News headline image
    The 7.5% Solution: Navigating the High-Yield Landscape of 2026
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Investing $122,100 in These 3 High-Yield Dividend Stocks Could Make You $10,000 in Reliable Passive Income in 2026 ↗
    Via The Motley Fool
    News headline image
    Navigating the Narrowing Path: Ares Capital’s High-Yield Resilience Meets the 2026 Margin Squeeze
    Via MarketMinute
    Topics Earnings Economy Regulatory Compliance
    News headline image
    Where Will Ares Capital Be in 3 Years? ↗
    Via The Motley Fool
    News headline image
    Want to Make Over $1,000 of Passive Income in 2026? Invest $12,500 in These 5 Ultra-High-Yielding Dividend Stocks. ↗
    Via The Motley Fool
    News headline image
    My 5 Favorite Ultra-High-Yield Dividend Stocks to Buy for 2026 ↗
    Via The Motley Fool
    Topics Energy
    News headline image
    5 Top Dividend Stocks Yielding More Than 5% to Buy in 2026 ↗
    Via The Motley Fool
    News headline image
    Should You Buy Ares Capital (ARCC) Stock Before February? ↗
    Via The Motley Fool
    Topics Economy
    News headline image
    Is Ares Capital a Buy, Sell, or Hold in 2026? ↗
    Via The Motley Fool
    Topics Bankruptcy
    News headline image
    Why I'm Buying These 3 Ultra-High-Yield Dividend Stocks Hand Over Fist for 2026 ↗
    Via The Motley Fool
    Topics Energy
    News headline image
    3 Monster Dividend Stocks Yielding As Much As 13.6% ↗
    Via The Motley Fool
    News headline image
    Better Dividend Stock: Ares Capital vs. Verizon Communications ↗
    Via The Motley Fool
    Topics Earnings Initial Public Offering
    News headline image
    The Best Dividend Stocks to Buy With $2,000 Right Now ↗
    Via The Motley Fool
    News headline image
    The Best Dividend Stocks to Buy and Hold Forever ↗
    Via The Motley Fool
    News headline image
    The Great Divergence: Dow Soars to Record Highs While Nasdaq Tech Stumbles
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    3 Top Dividend Stocks to Buy in December ↗
    Via The Motley Fool
    Topics Initial Public Offering Intellectual Property
    News headline image
    Is Ares Capital Stock a Buy Now? ↗
    Via The Motley Fool
    Topics Bonds
    News headline image
    Should You Buy Ares Capital Corporation Stock While It's Below $21? ↗
    Via The Motley Fool
    Topics Economy

    Frequently Asked Questions

    Is Ares Capital Corporation - Closed End Fund publicly traded?
    Yes, Ares Capital Corporation - Closed End Fund is publicly traded.
    What exchange does Ares Capital Corporation - Closed End Fund trade on?
    Ares Capital Corporation - Closed End Fund trades on the Nasdaq Stock Market
    What is the ticker symbol for Ares Capital Corporation - Closed End Fund?
    The ticker symbol for Ares Capital Corporation - Closed End Fund is ARCC on the Nasdaq Stock Market
    What is the current price of Ares Capital Corporation - Closed End Fund?
    The current price of Ares Capital Corporation - Closed End Fund is 20.38
    When was Ares Capital Corporation - Closed End Fund last traded?
    The last trade of Ares Capital Corporation - Closed End Fund was at 01/07/26 11:58 AM ET
    What is the market capitalization of Ares Capital Corporation - Closed End Fund?
    The market capitalization of Ares Capital Corporation - Closed End Fund is 14.59B
    How many shares of Ares Capital Corporation - Closed End Fund are outstanding?
    Ares Capital Corporation - Closed End Fund has 15B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.